While seldom mutated in cancer, the range of tumors in which aberrant NAV3 expression was encountered is extensive: colorectal, breast, melanoma, adrenal carcinoma, glioblastoma and neuroblastoma34–36. The gene discussed is NAV3; the disease is adrenal carcinoma.